-
August 24, 2012
GlaxoSmithKline (GSK) and Janssen Biologics' (Ireland) human anti-interleukin (IL)-6 monoclonal antibody, sirukumab ...
-
August 24, 2012
Pharmacyclics, Inc. (PCYC) recently announced the enrollment of the fifth patient in a phase II study that is being ...
-
August 24, 2012
Recently, health care products major Covidien plc. (COV) has been hit by a number of product recalls, the most ...
-
August 23, 2012
We have reiterated our Neutral rating on CR Bard Inc. (BCR) following its second quarter results, where adjusted ...
-
August 23, 2012
Alexza Pharmaceuticals, Inc. (ALXA) recently announced that it has received its EU certificate of Good Manufacturing ...
-
August 22, 2012
The US Food and Drug Administration (FDA) recently extended its review period for Pfizer's (PFE) rheumatoid ...
-
August 17, 2012
Leading medical instruments and supplies company Covidien plc. (COV) has extended its support for the recently ...
-
August 15, 2012
Pfizer has filed plans to sell up to 20% of its animal-health unit in the first half of 2013 to focus on human ...
-
August 14, 2012
Elan Corporation (ELN) recently announced its decision to split into two separate publicly traded companies. The ...
-
August 13, 2012
We reiterate our Neutral recommendation on Covidien plc. (COV). The company's adjusted earnings per share (from ...
-
August 13, 2012
The performance of healthcare stocks (as measured by ETFs) has begun to falter a bit, likely in part because Johnson ...
-
August 08, 2012
We reaffirm our Neutral recommendation on Stryker Corp. (SYK). Stryker reported second quarter 2012 adjusted ...
-
August 08, 2012
The week ahead for healthcare stocks.
-
August 08, 2012
Onyx Pharmaceuticals Inc. (ONXX) reported second quarter 2012 loss per share of 85 cents, wider than the Zacks ...
-
August 07, 2012
Medivation, Inc. (MDVN) and Astellas Pharma Inc. recently announced that the US Food and Drug Administration (FDA) ...
-
August 07, 2012
Pfizer, Inc. (PFE) recently announced disappointing late-stage results on intravenous (IV) bapineuzumab. ...
-
August 07, 2012
DexCom (DXCM), a player in the glucose monitoring market, reported second-quarter 2012 loss per share of 21 cents, ...
-
August 06, 2012
Leading healthcare products maker Covidien plc. (COV) recently announced the inauguration of its latest Research and ...
-
August 03, 2012
SurModics Inc.'s (SRDX) third quarter fiscal 2012 earnings from continued operations (excluding special items) of 17 ...
-
August 02, 2012
Bayer's (BAYRY) earnings per share during the second quarter of 2012 came in at ¬1.47 (approx $1.89) compared with ...
